{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:26:28Z","timestamp":1771003588707,"version":"3.50.1"},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,4,22]],"date-time":"2007-04-22T00:00:00Z","timestamp":1177200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Aim<\/jats:bold> To evaluate the long\u2010term prognosis of patients diagnosed with drug\u2010induced liver injury, and the nature of the liver injury.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> Patients with a diagnosis of drug\u2010induced liver injury between 1994 and 2005 were identified in a university hospital clinic. Patients surviving drug\u2010induced liver injury\u2010associated liver failure were excluded.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> Seventy\u2010seven cases were identified and those who were alive (69) were invited to attend follow\u2010up. Of those patients who had died, none had died of liver disease. Of those patients who had survived, 59 were reviewed in the clinic. Patients had a median follow\u2010up of 48\u2003months. Before the diagnosis of drug\u2010induced liver injury, nine had a chronic liver disease, four with autoimmune hepatitis, two with non\u2010alcoholic liver disease, one each with non\u2010alcoholic fatty liver disease, primary biliary cirrhosis and primary sclerosing cholangitis. There was no evidence of progression of their liver disease during follow\u2010up. Among 50 patients without a known liver disease prior to the drug\u2010induced liver injury, 10 had abnormal liver tests. Diagnostic work\u2010up revealed alternative cause of liver disease in all except three patients (6%), who had asymptomatic abnormal liver tests (but normal bilirubin in all).<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> Chronic abnormalities in liver tests, not explained by an identified liver disease, are very rare in patients previously diagnosed with drug\u2010induced liver injury. This group of patients did not seem to have a clinically significant liver injury at long\u2010term follow\u2010up.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2007.03355.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T11:50:54Z","timestamp":1279885854000},"page":"79-85","source":"Crossref","is-referenced-by-count":48,"title":["Long\u2010term follow\u2010up of patients with mild to moderate drug\u2010induced liver injury"],"prefix":"10.1111","volume":"26","author":[{"given":"E.","family":"BJ\u00d6RNSSON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"KALAITZAKIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"AV KLINTEBERG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"ALEM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"OLSSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-12-200212170-00007"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20204"},{"issue":"240","key":"e_1_2_6_4_2","first-page":"48A","article-title":"Acute liver failure in Sweden: etiology and prognosis [Abstract]","volume":"39","author":"Wei G","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.5.731"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21424"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1967.tb10873.x"},{"key":"e_1_2_6_8_2","first-page":"1","article-title":"Causes and characteristics of 500 consecutive causes of jaundice","volume":"16","author":"Malchow\u2010M\u00f8ller A","year":"1981","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.3.409"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310000492"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(03)00032-1"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200610"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80476-3"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(77)80141-8"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(92)90029-O"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80362-6"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.5858\/2003-127-1493-RH","article-title":"Ramipril\u2010associated hepatotoxicity","volume":"127","author":"Yeung E","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i34.5394"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90887-5"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528109181815"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00365521.1974.12096796","article-title":"Sulfonamide\u2010induced chronic liver disease","volume":"9","author":"Tonder M","year":"1974","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)32568-5"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(05)80060-9"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1742-1241.1989.tb08690.x","article-title":"Chronic active hepatitis associated with diclofenac sodium therapy","volume":"43","author":"Mazeika PK","year":"1989","journal-title":"Br J Clin Pract"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000198941"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-80-1-1"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(87)80039-9"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5854.655"},{"key":"e_1_2_6_29_2","first-page":"1225","article-title":"Chronic hepatitis related to use of fluoxetine","volume":"92","author":"Johnston DE","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_30_2","first-page":"235","article-title":"[Liver cirrhosis due to chronic use of nitrofurantoin]","volume":"148","author":"Volbeda F","year":"2004","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6127.1591"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03117.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(93)90101-6"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(90)90124-A"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02133.x"},{"key":"e_1_2_6_36_2","first-page":"81","article-title":"Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?","volume":"49","author":"Devereaux BM","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20800"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2005.05.006"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2007.03355.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2007.03355.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:41:59Z","timestamp":1697240519000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2007.03355.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,22]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1111\/j.1365-2036.2007.03355.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03355.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,22]]}}}